nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—rheumatoid arthritis—osteoarthritis	0.977	1	CtDrD
Leflunomide—AHR—Adipogenesis—FRZB—osteoarthritis	0.00244	0.114	CbGpPWpGaD
Leflunomide—Niflumic Acid—PTGS2—osteoarthritis	0.00126	1	CrCbGaD
Leflunomide—PTK2B—Integrins in angiogenesis—COL2A1—osteoarthritis	0.000695	0.0325	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000684	0.0321	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—BGLAP—osteoarthritis	0.000681	0.0319	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—HSPA5—osteoarthritis	0.000613	0.0287	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—BMP2—osteoarthritis	0.000582	0.0273	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MMP13—osteoarthritis	0.000576	0.027	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.000491	0.023	CbGpPWpGaD
Leflunomide—PTK2B—Alpha4 beta1 integrin signaling events—FN1—osteoarthritis	0.000484	0.0227	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000468	0.0219	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000457	0.0214	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MMP2—osteoarthritis	0.000431	0.0202	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MMP3—osteoarthritis	0.000386	0.0181	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—SMAD3—osteoarthritis	0.000365	0.0171	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000355	0.0166	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1RN—osteoarthritis	0.000338	0.0158	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000332	0.0155	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000332	0.0155	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MMP9—osteoarthritis	0.000324	0.0152	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—MMP1—osteoarthritis	0.000316	0.0148	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—LEP—osteoarthritis	0.000312	0.0146	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MMP1—osteoarthritis	0.000308	0.0144	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000302	0.0141	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—BMP2—osteoarthritis	0.000295	0.0138	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—FN1—osteoarthritis	0.000289	0.0135	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—FMOD—osteoarthritis	0.000288	0.0135	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.000286	0.0134	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1A—osteoarthritis	0.000281	0.0132	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.000264	0.0124	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IGF1—osteoarthritis	0.000258	0.0121	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000258	0.0121	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—IGF1—osteoarthritis	0.000253	0.0118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1A—osteoarthritis	0.000243	0.0114	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—MMP2—osteoarthritis	0.000242	0.0113	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGES—osteoarthritis	0.000235	0.011	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—LEP—osteoarthritis	0.00022	0.0103	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—MMP9—osteoarthritis	0.000208	0.00975	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.000207	0.0097	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—CAMK2B—osteoarthritis	0.000203	0.00953	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—CXCL8—osteoarthritis	0.000201	0.00941	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—MMP9—osteoarthritis	0.000182	0.00851	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GSTO1—osteoarthritis	0.000166	0.00776	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—osteoarthritis	0.000163	0.00761	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—BGN—osteoarthritis	0.00016	0.00752	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00016	0.00751	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.000158	0.00738	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TGFB1—osteoarthritis	0.000155	0.00725	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—osteoarthritis	0.000147	0.00687	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—MMP9—osteoarthritis	0.000146	0.00684	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—osteoarthritis	0.000144	0.00677	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—osteoarthritis	0.000144	0.00676	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.000137	0.00642	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—osteoarthritis	0.000127	0.00594	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—osteoarthritis	0.000117	0.00546	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.000116	0.00542	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—TGFB1—osteoarthritis	0.000114	0.00534	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.000113	0.00531	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—osteoarthritis	8.59e-05	0.00402	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—osteoarthritis	8.22e-05	0.00385	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	7.92e-05	0.00371	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	7.81e-05	0.00366	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	7.54e-05	0.00353	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IHH—osteoarthritis	7.48e-05	0.0035	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MCF2L—osteoarthritis	7.48e-05	0.0035	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	7.48e-05	0.0035	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—osteoarthritis	7.42e-05	0.00348	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—osteoarthritis	7.06e-05	0.00331	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	6.76e-05	0.00317	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	6.67e-05	0.00313	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CAMK2B—osteoarthritis	6.65e-05	0.00311	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSK—osteoarthritis	6.65e-05	0.00311	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	5.92e-05	0.00277	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—osteoarthritis	5.91e-05	0.00277	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—COL9A2—osteoarthritis	5.49e-05	0.00257	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	5.41e-05	0.00253	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—COL9A1—osteoarthritis	5.33e-05	0.0025	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HSPA5—osteoarthritis	5.29e-05	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1RN—osteoarthritis	5.15e-05	0.00241	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	5.06e-05	0.00237	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	5.03e-05	0.00236	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FMOD—osteoarthritis	4.67e-05	0.00219	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS2—osteoarthritis	4.61e-05	0.00216	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	4.31e-05	0.00202	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	3.91e-05	0.00183	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGES—osteoarthritis	3.8e-05	0.00178	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1A—osteoarthritis	3.7e-05	0.00174	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	3.69e-05	0.00173	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—BMP2—osteoarthritis	3.65e-05	0.00171	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	3.65e-05	0.00171	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	3.65e-05	0.00171	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—osteoarthritis	3.46e-05	0.00162	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—osteoarthritis	3.1e-05	0.00145	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTO1—osteoarthritis	2.68e-05	0.00126	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—BGN—osteoarthritis	2.6e-05	0.00122	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP3—osteoarthritis	2.53e-05	0.00119	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FMOD—osteoarthritis	2.36e-05	0.0011	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SMAD3—osteoarthritis	2.29e-05	0.00107	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FMOD—osteoarthritis	2.01e-05	0.000944	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—osteoarthritis	1.96e-05	0.000918	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—osteoarthritis	1.93e-05	0.000905	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGES—osteoarthritis	1.92e-05	0.0009	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ESR1—osteoarthritis	1.87e-05	0.000876	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FN1—osteoarthritis	1.85e-05	0.000865	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGES—osteoarthritis	1.64e-05	0.000769	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—osteoarthritis	1.62e-05	0.000758	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTO1—osteoarthritis	1.35e-05	0.000634	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BGN—osteoarthritis	1.31e-05	0.000614	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—osteoarthritis	1.3e-05	0.00061	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—osteoarthritis	1.18e-05	0.000552	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTO1—osteoarthritis	1.16e-05	0.000542	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—osteoarthritis	1.13e-05	0.00053	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BGN—osteoarthritis	1.12e-05	0.000525	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—osteoarthritis	9.7e-06	0.000455	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	8.46e-06	0.000396	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—osteoarthritis	7.46e-06	0.00035	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—osteoarthritis	7.31e-06	0.000343	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	7.23e-06	0.000339	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—osteoarthritis	3.77e-06	0.000177	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—osteoarthritis	3.22e-06	0.000151	CbGpPWpGaD
